Sanofi SA (SASY)

89.60
-0.15(-0.17%)
  • Volume:
    4,027
  • Bid/Ask:
    89.51/89.60
  • Day's Range:
    89.60 - 91.05
Earnings results expected in 7 days

Sanofi will announce its quarterly financial results in 7 days. Traders should take this into account as the share price often fluctuates around this time period.

SASY Overview

Prev. Close
89.75
Day's Range
89.6-91.05
Revenue
-
Open
89.83
52 wk Range
76.45-106.08
EPS
-
Volume
4,027
Market Cap
112.1B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
5,954
P/E Ratio
17.56
Beta
-
1-Year Change
-0.73%
Shares Outstanding
1,247,405,732
Next Earnings Date
03 Feb 2023
What is your sentiment on Sanofi?
or
Market is currently closed. Voting is open during market hours.

Sanofi SA News

Sanofi SA Analysis

Sanofi SA Company Profile

Sanofi SA Company Profile

Employees
95442
Market
France
  • Type:Equity
  • Market:Germany
  • ISIN:FR0000120578
  • WKN:920657

Sanofi SA is a healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme, among others.

Read More

Analyst Price Target

Average102.44 (+14.17% Upside)
High134.00
Low57.4393
Price89.72
No. of Analysts24
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellNeutralStrong Buy
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellBuy
SummaryStrong SellStrong SellStrong SellSellStrong Buy
  • Will eventually do well because of French strategy. France is at the top table and Sanofi was made up by absorbing others to grow. Look at 20% in a couple of years
    0
    • there is no future for it
      9